Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02462499

Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Chronic Central Serous Chorioretinopathy Clinical Trial

Official title:
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Clinical Trial Summary

The aim of the study is to determine the efficacy and safety of treatment with the drug eplerenone in patients with chronic central serous chorioretinopathy.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02462499
Study type Interventional
Source Semmelweis University
Contact
Status Completed
Phase Phase 4
Start date June 2014
Completion date September 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01434095 - Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy N/A
Completed NCT00489840 - Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Phase 1/Phase 2
Completed NCT00211393 - A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole Phase 2
Not yet recruiting NCT02799992 - Pseudo-PDT in Central Serous Chorioretinopathy N/A
Completed NCT01325181 - Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy Phase 1/Phase 2
Completed NCT00211445 - Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) Phase 2
Active, not recruiting NCT03079141 - Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy Phase 4
Recruiting NCT05633576 - Steroid Eye Drops in Chronic Central Serous Chorioretinopathy Phase 3
Completed NCT01797861 - Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy Phase 4
Completed NCT04224831 - Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma N/A